Cargando…
A Case of Advanced Non-Small-Cell Lung Cancer With Response to Alectinib and Favorable Quality of Life
Lung cancer is the leading cause of cancer death globally and in the United States. Non-small-cell lung cancer (NSCLC) accounts for approximately 85% of lung cancer cases. A progressive increase in morbidity and mortality is seen with advanced disease. Identifying specific driver mutations, such as...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834647/ https://www.ncbi.nlm.nih.gov/pubmed/35165619 http://dx.doi.org/10.7759/cureus.21170 |